Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

13 Aug 2021 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated August 13, 2021 titled ‘Zydus Cadila receives final approval from USFDA for Mesalamine Extended-Release Capsules’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..